Source of Chronic Inflammation in Aging.

Sanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R. · 2018

Read Source of Chronic Inflammation in Aging. by Sanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5850851.txt.

Introduction

Sanada and co-authors hunt the sources of the chronic inflammation that shadows aging. Their review appeared in Frontiers in Cardiovascular Medicine. The smoldering state, dubbed inflammaging, needs no infection to persist. It raises the odds of heart disease, diabetes, and cancer.

Senescent cells are one fountain, leaking inflammatory signals as they linger. An aging immune system misfires in ways that keep the fire lit. Even clotting factors moonlight as inflammation triggers through their receptors. The inflammation outlasts the stimuli that first provoked it. Clearing senescent cells is floated as one anti-aging strategy.

Catalog record

CREATORSanada F, Taniyama Y, Muratsu J, Otsu R, Shimizu H, Rakugi H, Morishita R.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5850851

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Source of Chronic Inflammation in Aging By Fumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, Rei Otsu, Hideo Shimizu, Hiromi Rakugi, Ryuichi Morishita Published in: Frontiers in Cardiovascular Medicine DOI: 10.3389/fcvm.2018.00012 ABSTRACT Aging is a complex process that results from a combination of environmental, genetic, and epigenetic factors. A chronic pro-inflammatory status is a pervasive feature of aging. This chronic low-grade inflammation occurring in the absence of overt infection has been defined as “inflammaging” and represents a significant risk factor for morbidity and mortality in the elderly. The low-grade inflammation persists even after reversing pro-inflammatory stimuli such as LDL cholesterol and the renin–angiotensin system (RAS). Recently, several possible sources of chronic low-grade inflammation observed during aging and age-related diseases have been proposed. Cell senescence and dysregulation of innate immunity is one such mechanism by which persistent prolonged inflammation occurs even after the initial stimulus has been removed. Additionally, the coagulation factor that activates inflammatory signaling beyond its role in the coagulation system has been identified. This signal could be a new source of chronic inflammation and cell senescence. Here, we summarized the factors and cellular pathways/processes that are known to regulate low-grade persistent inflammation in aging and age-related disease. INTRODUCTION At present, chronic inflammation is thought to be a risk factor for a broad range of age-related diseases such as hypertension, diabetes, atherosclerosis, and cancer. (1) Although age-related diseases may be partially preventable with lifestyle modifications, including diet, the burdens of unhealthy aging associated with lifestyle are increasing, both in developed and developing regions. Therefore, the elucidation of the sources and cellular pathways/processes of chronic inflammation is an urgent task. There are several possible factors that initiate and maintain a low-grade inflammatory response. These include aging, unbalanced diet, low level of sex hormones, and smoking. In contrast to young individuals, aged individuals have consistently elevated levels of inflammatory cytokines, especially interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) (2), which may induce muscle atrophy and cancer through DNA damage. Visceral fat tissue from obese individuals can also produce both IL-6 and TNF-α, affecting systemic metabolism (3, 4). The accumulation of macrophages in visceral fat seems to be proportional to body mass index and appears to be a major source of low-grade persistent, systemic inflammation and insulin resistance in obese individuals (5, 6). Cigarette smoke contains multiple inducers of inflammation, especially reactive oxygen species. Indeed, chronic smoking increases production of several pro-inflammatory cytokines such as IL-6, TNF-α, and interleukin-1β (IL-1β) (7). Smoking also increases systemic inflammation and is an independent risk factor for several lifestyle-related diseases. Other inciting factors such as mental stress and periodontal disease have been reported. Importantly, the low-grade inflammation persists even after reversing the pro-inflammatory stimuli such as LDL cholesterol, the renin–angiotensin system (RAS), and smoking. These findings can be explained by the discovery of senescent associated secretory phenotype (SASP) and immunological imprinting. In this narrative review, we aimed to review the sources of chronic inflammation during aging (Figure 1). The cellular pathways/processes that are known to regulate the DNA damage response are also discussed. [Figure: Source of “inflammaging”. Among the main causes of inflammaging, the accumulation of cell senescence, pro-coagulation factors, cell debris such as circulating mitochondrial DNA (cmtDNA), gut dysbiosis, and immune senescence is known to be the main causes of inflammaging. Inflammaging can also be influenced by many other factors, including age itself, reactive oxygen species (ROS), and those not directly related to inflammation, such as microRNAs (miRs) and agalactosylated N-glycans.] SOURCE OF CHRONIC INFLAMMATION IN AGING Acute inflammation is indispensable for immune responses to invading pathogens or acute traumatic injuries. This process enables repair and cell turnover in multiple tissues. In contrast, chronic inflammation normally causes low-grade and persistent inflammation, leading to tissue degeneration. (8). Chronic, low-grade inflammation is a crucial contributor to various age-related pathologies and natural processes in aging tissue, including the nervous and the musculoskeletal system (9). Many tissues in the elderly are chronically inflamed, and inflammatory cytokines such as IL-6, IL-1β, and TNF-α are known to weaken the anabolic signaling cascade, including insulin and erythropoietin signaling, leading to the development of sarcopenia (10). The possible sources of chronic inflammation during aging, termed “inflammaging”, have been described previously (9). Cell Debris or Immunoglobulin Accumulation Debris and immunoglobulin accumulation due to inappropriate cell elimination systems in aging trigger the innate immune system activation leading to persist inflammation. Glycosylation represents the most frequent post-translational modification of proteins. Protein-linked sugar chains play a variety of specific roles in the “fine-tuning” of interactions between cells and between molecules (11, 12). High-throughput analysis of the N-glycome, i.e., the sugar chains N-linked to asparagine, revealed new candidate biomarkers of natural aging, such as N-glycans devoid of galactose residues on their branches, in a variety of human studies (13–15) comparing healthy elderly people, centenarians, and their offspring, as well as in experimental animal models (16–18), such as the calorie-restricted mice model. These agalactosylated biantennary structures mainly decorate Asn297 of the Fc portion of IgG (IgG-G0) and are present in patients affected by progeria syndromes as well as a several autoimmune/inflammatory diseases. IgG-G0 exerts a pro-inflammatory effect through various mechanisms, including the lectin pathway of complement, binding to Fcγ receptors and formation of autoantibody aggregates. Similarly, the age-related accumulation of IgG-G0 activating the immune system can contribute to inflammaging. On the other hand, among the complex determinants of aging, mitochondrial dysfunction has attracted attention for some time. The consequences of age-related failing mitochondrial quality control include the release of mitochondria-derived damage-associated molecular patterns (DAMPs). Mitochondrial DAMPs, especially cell-free circulating mitochondrial DNA, have recently become the subject of intensive research because of their possible involvement in conditions associated with inflammation, such as aging and degenerative diseases (19, 20). Through their bacterial ancestry, these molecules contribute to increasing an inflammatory response by interacting with receptors similar to those involved in pathogen-associated responses. The Gut Mucosa and Microbiota of Elderly People The barrier of the oral and gut mucosa against bacterial invasion deteriorates with age. Periodontal disease has also demonstrated to cause chronic low-grade inflammation (12). The gut microbiota of elderly people displays decreased diversity (21, 22). The abundance of anti-inflammatory microbiota, such as members of Clostridium cluster XIVa, Bifidobacterium spp., and F. prausnitzii are diminished in aged individuals (23). Toward R et al. demonstrated supportive data that the level of Bifidobacterium is inversely correlated with serum levels of inflammatory cytokines, such as TNF-α and IL-1β. Conversely, inflammatory and pathogenic microbiota, including Streptococcus spp., Staphylococcus spp., Enterococcus spp. and Enterobacter spp., are increased with age (23). Changes in the gut microbiota diversity in aged people might increase susceptibility to infectious agents by pathobionts colonization. Unique stool microbiota profiles were evident between healthy “community-dwelling elderly” and subjects with “residential long-term care” (24). These differences might be due to the disparate consumption of food in various groups, suggesting a new therapeutic target for prolonged healthy life years. Cell Senescence Cellular senescence is defined as irreversible cell cycle arrest driven by a variety of mechanisms, including telomere shortening, genotoxic stress, mitogen stimuli, and inflammatory cytokines, that result in the activation of the p53 tumor suppressor and/or the cyclin-dependent kinase inhibitor p16 (25). It is evident that the number of senescent cells in several organs increases with age;

Read the complete text